LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,373.00
+6.57%Forward multiples
Based on analyst estimates
- P/E forward
- 31.12x
- P/E 2026E
- 40.48x
- P/E 2027E
- 28.94x
- P/E 2028E
- 25.28x
- P/S forward
- 13.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- 45.94x
- PEG TTM
- 0.97x
- Price / book
- 38.15x
- Price / sales
- 16.22x
- Price / cash flow
- 46.02x
Enterprise value
- Enterprise value
- $1.34T
- EV / sales
- 16.80x
- EV / EBITDA
- 30.91x
- EV / EBIT
- 33.79x
- Market cap
- $1.29T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026